Biotage AB (publ) provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems and flash system accessories; normal, reversed, and speciality phase cartridges; plasmid purification solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, and government authorities and academic institutions, as well as clinical, forensic, and academic laboratories. It operates in 70 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.

Biotage AB (publ)

Biotage provides solutions for drug discovery and development, analytics, and environmental testing.

Metric
Company Name	Biotage AB (publ)
Symbol	BIOT
MSH ID	COM:BIOTAGE
Market	STOCKS
Sector	Healthcare
Industry	Medical - Instruments & Supplies
Country	SE
Stage
Employee Count	669
Website	biotage.com
LinkedIn
Founders

Metric
Market Cap	1.21B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	170.36M
Revenue (LTM)
Revenue (NTM)
Gross Profit	105.13M
EBITDA	43.00M
Operating Income	29.37M
Net Income	22.51M
EPS	0.30
Diluted EPS	0.30
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.63
Operating Profit Margin	0.18
EBITDA Margin	0.25
Net Profit Margin	0.13
Return on Equity	0.08
Return on Assets	0.05
Return on Capital Employed	0.09

BIOT

COM:BIOTAGE

Biotage

Last Close

155.00

25/11 09:40

Market Cap

13.17B

Beta: -

Volume Today

6.29K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	62.85
P/B Ratio	3.22
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	7.67
EV Multiple	30.14

Metric
Days Sales Outstanding
Days Payables Outstanding	102.27
Days Inventory Outstanding	224.00
Operating Cycle	305.26
Cash Conversion Cycle	265.73
Asset Turnover	0.43

Metric
Operating Cash Flow	25.98M
Free Cash Flow	17.66M
Cash Flow to Debt	1.08
Operating Cash Flow/Sales	0.21
Free Cash Flow Yield	0.02

Metric
Cash & Equivalents	54.35M
Accounts Receivable	-8.87M
Inventory	39.98M
Goodwill	218.76M
Debt to Capitalization	0.13
Debt to Assets	0.08
Current Ratio	1.89
Quick Ratio	1.52

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue	0.09
SG&A to Revenue	0.12